Caricamento...
Molecular targets in melanoma: time for `ethnic personalization'
Worldwide, the incidence of melanoma continues to rise. Although not the most common cutaneous malignancy, it is the most lethal. Until recently, while other oncologic patients benefited from the nuances of targeted therapy, those afflicted with melanoma lacked that option. In 2011, the US FDA appro...
Salvato in:
| Pubblicato in: | Expert Rev Anticancer Ther |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4877024/ https://ncbi.nlm.nih.gov/pubmed/22594895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/era.12.39 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|